BlockBeats News, on June 12, German natural cosmetics company Evertz Pharma GmbH announced that it had acquired an additional 100 Bitcoins (BTC) in May this year, valued at approximately 10 million euros (around 10.8 million USD).
Dominik Evertz, the Managing Director of Evertz Pharma, stated that Bitcoin, as a strategic asset, aligns closely with the company's vision for future resilience and stability. Chief Financial Officer Tobias Evertz added that the company will continue to evaluate sustainable ways to increase its Bitcoin reserves.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.